Results 261 to 270 of about 1,880,201 (344)

An improved procedure based on fluorescence immunochromatography for rapid detection of group B streptococcus from enrichment cultures. [PDF]

open access: yesBMC Pregnancy Childbirth
Chen X   +9 more
europepmc   +1 more source

Microbial decolorization of a textile azo dye Novacron Blue by natural inhabitant bacteria

open access: yesEnvironmental Progress &Sustainable Energy, EarlyView.
Abstract Azo dye discharged in wastewater streams from textile or other industry without treatment results in environmental pollution. This study attempts to uncover the ability of naturally occurring bacteria in reducing and decolorizing a textile azo dye Novacron Blue in nutrient medium and also from textile dye effluent.
Jannatul Ferdousi   +2 more
wiley   +1 more source

Evaluation of Peptide-Based Vaccines Against <i>Group A Streptococcus</i> in <i>Staphylococcus aureus</i>-Infected Mice. [PDF]

open access: yesVaccines (Basel)
Shalash AO   +9 more
europepmc   +1 more source

Mercuric Reductase Enzymes from Streptomyces Species and Group B Streptococcus

open access: bronze, 1985
Hiromichi Nakahara   +6 more
openalex   +1 more source

Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials

open access: yesExploration, EarlyView.
Intra‐tumoral microbiota, which is a potential component of the tumor microenvironment, has been emerging as a key participant and driving factor in cancer. This article reviews the latest progress in this field, including the microbial community within tumors and its pro‐cancer mechanisms, as well as the anti‐tumor strategies targeting intra‐tumoral ...
Yanan Niu   +4 more
wiley   +1 more source

Development of a Promising Bivalent Vaccine Against Klebsiella pneumoniae Based on Glycoengineered GMMA (geGMMA)

open access: yesExploration, EarlyView.
Multidrug‐resistant Klebsiella pneumoniae poses a significant threat as a nosocomial pathogen, with no current licensed vaccines available. This study used a mutant E. coli strain expressing exogenous polysaccharides (from K. pneumoniae) to establish glycoengineered generalized modules for membrane antigens (geGMMA) vaccine platform, which demonstrated
Jingqin Ye   +13 more
wiley   +1 more source

Synthetic Biology‐Based Engineering Living Therapeutics for Antimicrobial Application

open access: yesExploration, EarlyView.
This perspective highlights synthetic biology‐driven antibacterial strategies, focusing on three innovative approaches: engineered bacteriophages for precision bacterial targeting, reprogrammed microbes that detect quorum‐sensing signals or metabolites to release antimicrobials, and engineering mammalian cells that recognize pathogen‐associated ...
Shun Huang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy